Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : UTHR save search
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: -1.0%
conference international commercial therapeutics
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
Published: 2024-03-26 (Crawled : 12:30) - biospace.com/
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.17%
H: 2.54%
C: 1.3%
first review publication therapeutics
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 10:00) - globenewswire.com
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.65%
H: 0.23%
C: -2.9%
LQDA M | $13.82 0.07% 69K
|
Health Technology
|
| O: 0.64%
H: 5.54%
C: 4.69%
year corporation update financial results
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
Published: 2024-03-05 (Crawled : 12:30) - biospace.com/
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -0.19%
H: 1.76%
C: 0.66%
conference corporation biopharma global therapeutics
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-27 (Crawled : 12:00) - biospace.com/
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.15%
H: 2.13%
C: 1.27%
conference health corporation care therapeutics
Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2024-02-26 (Crawled : 15:00) - prnewswire.com
AZNCF | $138.24 -1.36% 0
|
Health Technology
|
| O: 3.06%
H: 0.0%
C: -2.34%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.23%
H: 1.16%
C: 0.08%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: -0.19%
H: 0.23%
C: -2.02%
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -0.48%
H: 1.17%
C: -1.04%
AZN | $68.505 0.21% 580K
|
Health Technology
|
| O: 0.38%
H: 0.44%
C: -0.23%
reach research market
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: -2.33%
H: 1.55%
C: 1.06%
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 2.59%
H: 3.66%
C: -0.24%
year corporation therapeutics financial results
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024
Published: 2024-02-14 (Crawled : 12:00) - biospace.com/
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -0.29%
H: 0.72%
C: 0.61%
report year corporation therapeutics financial results market
Wearable Injectors Market Worth $15.1 Billion | MarketsandMarkets™
Published: 2024-02-09 (Crawled : 15:30) - prnewswire.com
MDT | $79.45 0.33% 820K
|
Health Technology
|
| O: -0.12%
H: 0.09%
C: -1.27%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.18%
H: 0.11%
C: 0.1%
TNDM | $30.83 -0.32% 94K
|
Health Technology
|
| O: 0.22%
H: 1.06%
C: 0.34%
MNKD | $4.12 0.98% 150K
|
Health Technology
|
| O: 1.46%
H: 0.86%
C: 0.86%
PODD | $166.31 0.96% 46K
|
Health Technology
|
| O: 0.14%
H: 0.28%
C: -2.21%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: 0.0%
H: 0.05%
C: -1.27%
market
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
Published: 2024-01-25 (Crawled : 11:00) - globenewswire.com
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.54%
H: 1.08%
C: -0.31%
LQDA M | $13.82 0.07% 69K
|
Health Technology
|
| O: -7.63%
H: 12.84%
C: 7.45%
drug corporation update application
Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims
Published: 2024-01-08 (Crawled : 13:30) - globenewswire.com
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -0.61%
H: 1.34%
C: 1.33%
LQDA M | $13.82 0.07% 69K
|
Health Technology
|
| O: 0.79%
H: 1.41%
C: 0.78%
corporation therapeutics response
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
Published: 2024-01-05 (Crawled : 12:00) - globenewswire.com
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -0.41%
H: 0.73%
C: 0.1%
LQDA M | $13.82 0.07% 69K
|
Health Technology
|
| O: 3.06%
H: 4.99%
C: 0.24%
update pipeline
Liquidia Corporation Announces $100 Million in New Financings
Published: 2024-01-04 (Crawled : 14:30) - globenewswire.com
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -0.04%
H: 1.06%
C: 0.89%
LQDA M | $13.82 0.07% 69K
|
Health Technology
|
| O: 0.88%
H: 9.33%
C: 7.03%
million corporation
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
Published: 2024-01-02 (Crawled : 11:00) - globenewswire.com
MS | News 0 d | $90.92 0.73% 950K
|
Finance
|
| O: -0.63%
H: 1.61%
C: 1.34%
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -0.08%
H: 4.01%
C: 3.47%
MNKD | $4.12 0.98% 150K
|
Health Technology
|
| O: 1.92%
H: 11.59%
C: 5.66%
million royalty agreement
U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)
Published: 2023-12-20 (Crawled : 22:00) - globenewswire.com
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.18%
H: 0.39%
C: -3.39%
LQDA M | $13.82 0.07% 69K
|
Health Technology
|
| O: 3.64%
H: 4.51%
C: 1.62%
patent therapeutics
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
Published: 2023-12-13 (Crawled : 15:30) - biospace.com/
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -0.27%
H: 2.49%
C: 2.36%
medical therapeutics
Pulmonary Arterial Hypertension Market Size Valuation Will Exceed USD 11.35 Billion By 2032, at 5.0% CAGR: Polaris Market Research
Published: 2023-11-29 (Crawled : 15:30) - prnewswire.com
VTRS | $11.26 1.26% 500K
|
Health Technology
|
| O: 0.11%
H: 0.44%
C: -0.22%
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.35%
H: 1.23%
C: 0.38%
GILD | News | $66.52 0.54% 780K
|
Health Technology
|
| O: 0.46%
H: 0.8%
C: 0.51%
research hypertension market
Sarcoidosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Key Players - Pfizer, United Therapeutics, Xentria, aTyr Pharma, Kyorin Pharmaceutical, Novartis, Kinevant Sciences
Published: 2023-11-02 (Crawled : 21:00) - prnewswire.com
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.73%
H: 0.63%
C: -2.35%
LIFE | $1.615 -0.31% 49K
|
Health Technology
|
| O: 0.78%
H: 1.54%
C: 0.0%
sciences growth market
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
Published: 2023-11-01 (Crawled : 11:00) - biospace.com/
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: -5.01%
H: 7.34%
C: 5.85%
corporation therapeutics financial results
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
Published: 2023-10-31 (Crawled : 11:00) - biospace.com/
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.31%
H: 0.73%
C: 0.7%
conference corporation biopharma therapeutics
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.